Ludovic Halby

CNRS, MEAE, 2-10 Norham Road
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs.

An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs.

Journal: Nature communications

Published: December 04, 2024

Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTs.

Design, synthesis and evaluation of pyrimidinobenzylamide and pyrimidinothiophenamide derivatives as inhibitors of DOT1L and related epigenetic targets DNMT3a, PRMT4 and other HMTs.

Journal: RSC medicinal chemistry

Published: November 15, 2024

Plasmodium falciparum Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstrate Inhibitors.

Plasmodium falciparum Eukaryotic Translation Initiation Factor 3 is Stabilized by Quinazoline-Quinoline Bisubstrate Inhibitors.

Journal: ACS infectious diseases

Published: May 22, 2023

Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum.

Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum.

Journal: iScience

Published: November 23, 2022

Inhibitors of DNA Methylation.

Inhibitors of DNA Methylation.

Journal: Advances in experimental medicine and biology

Published: November 09, 2022

Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies.

Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies.

Journal: Future medicinal chemistry

Published: March 25, 2022

Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein.

Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein.

Journal: Molecules (Basel, Switzerland)

Published: July 15, 2021

Towards the sustainable discovery and development of new antibiotics.

Towards the sustainable discovery and development of new antibiotics.

Journal: Nature reviews. Chemistry

Published: July 01, 2021

Towards the sustainable discovery and development of new antibiotics.

Towards the sustainable discovery and development of new antibiotics.

Journal: Nature reviews. Chemistry

Published: July 01, 2021

Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.

Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.

Journal: Journal of medicinal chemistry

Published: June 29, 2021

Direct Synthesis of Allyl Amines with 2-Nitrosulfonamide Derivatives via the Tsuji-Trost Reaction.

Direct Synthesis of Allyl Amines with 2-Nitrosulfonamide Derivatives via the Tsuji-Trost Reaction.

Journal: ChemistryOpen

Published: June 21, 2021

A novel screening strategy to identify histone methyltransferase inhibitors reveals a crosstalk between DOT1L and CARM1.

A novel screening strategy to identify histone methyltransferase inhibitors reveals a crosstalk between DOT1L and CARM1.

Journal: RSC chemical biology

Published: April 26, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026